glp 1 efficacy comparison Next-Gen Weight Loss Drugs Beyond GLP-1 Glucagon-like peptide 1 in health

Sneaky new trend companies are using to target GLP-1 and other weight-loss drug users While the nutritional needs of GLP-1 users are not drastically different from the general population, according to a dietician, the key distinction lies in reduced food intake Bookmark Supermarket shelves across the United States are increasingly featuring meals and snacks emblazoned with "GLP-1 Friendly" labels, a direct response to the growing number of Americans turning to obesity medications like Wegovy and Zepbound for weight loss

Last question is about side effects

[4] [5] For weight management, NICE technology appraisals (TA875 for Wegovy, TA664 for Saxenda) specify these treatments should be used within specialist weight management services (tier 3 or 4), with specific eligibility criteria, time-limited use, and defined stopping rules

For weight management, NICE technology appraisals specify eligibility criteria including minimum BMI thresholds and require initiation within specialist weight management services